TitleAssistant Professor
InstitutionMD Anderson
DepartmentClinical Cancer Prevention
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Thomas PS, Patel AB, Lee JJ, Liu DD, Hernandez M, Muzzio M, Contreras A, Sepeda V, Mays C, Weber D, Vornik LA, Khan SA, Dimond E, Heckman-Stoddard BM, Perloff M, Brown PH. Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer. Cancer Prev Res (Phila). 2023 01 04; 16(1):47-55. PMID: 36228112; PMCID: PMC10391360.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    2. Thomas PS, Class CA, Gandhi TR, Bambhroliya A, Do KA, Brewster AM. Demographic, clinical, and geographical factors associated with lack of receipt of physician recommended chemotherapy in women with breast cancer in Texas. Cancer Causes Control. 2019 Apr; 30(4):409-415. PMID: 30868330; PMCID: PMC7239038.
      Citations: 2     Fields:    Translation:Humans
    3. Bojadzieva J, Amini B, Day SF, Jackson TL, Thomas PS, Willis BJ, Throckmorton WR, Daw NC, Bevers TB, Strong LC. Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic. Fam Cancer. 2018 04; 17(2):287-294. PMID: 28988289.
      Citations: 15     Fields:    Translation:Humans
    4. Biomarker endpoints for early-phase cancer-prevention studies. Current Breast Cancer Reports. 5:194-201.
    5. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma in Situ. Breast Journal. 21:377-386.
    6. Why breast cancer risk by the numbers is not enough. Journal of Medical Internet Research. 17.
    THOMAS's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (34)
    Co-Authors (7)
    Similar People (60)
    Same Department Expand Description